Découvrez nos professeurs et professeures!

Louis Bessette

Médecin clinicien enseignant agrégé

Louis Bessette
Centre de recherche du CHU de Québec - Université Laval
Centre de recherche en arthrite (ARThrite)
Partager la fiche :

Contribution à la recherche

Axe de recherche de l'Université Laval :

Santé et bien-être durables

Thématiques de recherche de la Faculté de médecine :

Immunologie-infectiologie

Domaines et intérêts de recherche du (de la) professeur(e) :

Appareil locomoteur et arthrite
  • Arthrite/arthrose
  • Articulations

Projets de recherche

  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - La société d'arthrite, co-chercheur - 2020-01-01 au 2022-12-31

Publications

  • A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort, Kathleen M. Andersen, Orit Schieir, Marie‐France Valois, Susan J. Bartlett, Louis Bessette, Gilles Boire, Boulos Haraoui, Glen Hazlewood, Carol Hitchon, Edward C. Keystone, Janet Pope, Diane Tin, J Carter Throne, Vivian P. Bykerk, Murray Baron, Ines Colmegna, Sabrina Fallavollita, Derek Haaland, Paul Haraoui, Shahin Jamal, Raman Joshi, Ed Keystone, Bindu Nair, Peter Panopoulos, Laurence Rubin, Edith Villeneuve, Michel Zummer, ACR Open Rheumatology, 2022, 10.1002/acr2.11334
  • Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study, Fleischmann, R., Mysler, E., Bessette, L., Peterfy, C.G., Durez, P., Tanaka, Y., Swierkot, J., Khan, N., Bu, X., Li, Y., Song, I.-H., RMD Open, 2022, 10.1136/rmdopen-2021-002012
  • Reply, Fatima, S., Schieir, O., Keystone, E.C., Valois, M.F., Bartlett, S.J., Bessette, L., Boire, G., Hazlewood, G., Hitchon, C., Tin, D., Thorne, C., Bykerk, V.P., Pope, J.E., Arthritis and Rheumatology, 2022, 10.1002/art.41918
  • Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data, Claudia Beaudoin, Sonia Jean, Lynne Moore, Philippe Gamache, Louis Bessette, Louis‐Georges Ste‐Marie, Jacques P. Brown, Journal of Bone and Mineral Research, 2021, 10.1002/jbmr.4438
  • Expectations and educational needs of rheumatologists, rheumatology fellows and patients in the field of precision medicine in Canada, a quantitative cross-sectional and descriptive study, Ruel-Gagné, S., Simonyan, D., Légaré, J., Bessette, L., Fortin, P.R., Lacaille, D., Dogba, M.J., Michou, L., BMC Rheumatology, 2021, 10.1186/s41927-021-00222-2
  • Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis, Vaillancourt, M., Desaulniers, P., Paré, G., Pagé, N., Lachhab, A., Kerever, A., Julien, A.-S., Amiable, N., Pelletier, M., Tessier, P.A., Bessette, L., Michou, L., Fortin, P.R., Fernandes, M.J., Scientific Reports, 2021, 10.1038/s41598-021-90631-7
  • Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib, Dikranian, A., Gold, D., Bessette, L., Nash, P., Azevedo, V.F., Wang, L., Woolcott, J., Shapiro, A.B., Szumski, A., Fleishaker, D., Wollenhaupt, J., Rheumatology and Therapy, 2021, 10.1007/s40744-021-00405-w
  • Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis, Fatima, S., Schieir, O., Valois, M.F., Bartlett, S.J., Bessette, L., Boire, G., Hazlewood, G., Hitchon, C., Keystone, E.C., Tin, D., Thorne, C., Bykerk, V.P., Pope, J.E., Baron, M., Bessette, L., Boire, G., Bykerk, V., Colmegna, I., Fallavollita, S., Haaland, D., Haraoui, P., Hazlewood, G., Hitchon, C., Jamal, S., Joshi, R., Keystone, E., Nair, B., Panopoulos, P., Pope, J., Rubin, L., Thorne, C., Villeneuve, E., Zummer, M., Arthritis and Rheumatology, 2021, 10.1002/art.41513
  • Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort, Holdren, M., Schieir, O., Bartlett, S.J., Bessette, L., Boire, G., Hazlewood, G., Hitchon, C.A., Keystone, E., Tin, D., Thorne, C., Bykerk, V.P., Pope, J.E., Arthritis and Rheumatology, 2021, 10.1002/art.41499
  • Safety profile of upadacitinib in rheumatoid arthritis: Integrated analysis from the SELECT phase III clinical programme, Cohen, S.B., Van Vollenhoven, R.F., Winthrop, K.L., Zerbini, C.A.F., Tanaka, Y., Bessette, L., Zhang, Y., Khan, N., Hendrickson, B., Enejosa, J.V., Burmester, G.R., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218510
  • Switching between janus kinase inhibitor upadacitinib and adalimumab following insufficient response: Efficacy and safety in patients with rheumatoid arthritis, Fleischmann, R.M., Blanco, R., Hall, S., Thomson, G.T.D., Van Den Bosch, F.E., Zerbini, C., Bessette, L., Enejosa, J., Li, Y., Song, Y., Demasi, R., Song, I.-H., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218412
  • An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis, Pelletier, J.-P., Raynauld, J.-P., Dorais, M., Bessette, L., Dokoupilova, E., Morin, F., Pavelka, K., Paiement, P., Martel-Pelletier, J., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/keaa072
  • An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs, Pope, J., Rampakakis, E., Vaillancourt, J., Bessette, L., Lazovskis, J., Haraoui, B., Sampalis, J.S., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez470
  • Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos), Morin, S.N., Berger, C., Liu, W., Prior, J.C., Cheung, A.M., Hanley, D.A., Boyd, S.K., Wong, A.K.O., Papaioannou, A., Rahme, E., Goltzman, D., Kreiger, N., Tenenhouse, A., Rahme, E., Richards, J.B., Berger, C., Joyce, C., Kovacs, C.S., Kirkland, S., Kaiser, S.M., Brown, J.P., Bessette, L., Anastassiades, T.P., Towheed, T., Hopman, W.M., Cheung, A.M., Josse, R.G., Wong, A.K.O., Adachi, J.D., Papaioannou, A., Olszynski, W.P., Davison, K.S., Hanley, D.A., Boyd, S.K., Prior, J.C., Kalyan, S., Lentle, B., Patel, M.S., Jackson, S.D., Leslie, W.D., Archives of Osteoporosis, 2020, 10.1007/s11657-020-00822-4
  • Experience with tofacitinib in Canada: Patient characteristics and treatment patterns in rheumatoid arthritis over 3 years, Pope, J., Bessette, L., Jones, N., Fallon, L., Woolcott, J., Gruben, D., Crooks, M., Gold, D., Haraoui, B., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez324
  • Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks, Marzo-Ortega, H., Mease, P.J., Rahman, P., Navarro-Compán, V., Strand, V., Dougados, M., Combe, B., Wei, J.C.-C., Baraliakos, X., Hunter, T., Sandoval, D., Li, X., Zhu, B., Bessette, L., Deodhar, A., Rheumatology and Therapy, 2020, 10.1007/s40744-020-00225-4
  • Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial, Deodhar, A., van der Heijde, D., Gensler, L.S., Kim, T.-H., Maksymowych, W.P., Østergaard, M., Poddubnyy, D., Marzo-Ortega, H., Bessette, L., Tomita, T., Leung, A., Hojnik, M., Gallo, G., Li, X., Adams, D., Carlier, H., Sieper, J., Morin, F., Rahman, P., Ariel, F., Berman, A., Carrio, J., Lucero, E., Cocco, J.M., Hidalgo, R.P., Velasco, J., Viola, D.O., Grisar, J., Resch, H., Scheinecker, C., Melazzi, A.C., Roimicher, L., Scotton, A.S., Rodriguez, A.A.B., Molina, F.F.C., Barragan, S.D., Skinner, C.M., Tena, C.F.P., Remus, C.R.R., Rodriguez, J.C.R., Hong, S.-J., Kang, S.W., Lee, C.K., Lee, E.B., Lee, S.H., Park, M.-C., Lee, S.-H., Dokoupilova, E., Dvorak, Z., Malcova, M., Pvelka, K., Eklund, K.K., Jarvinen, P., Karjalainen, A., Paimela, L., Taniguchi, Y., Tsuda, T., Tada, K., Dobashi, H., Inui, K., Ueki, Y., Matsumoto, Y., Hatta, K., Atsumi, T., Goto, H., Honjo, S., Matsui, K., Takakubo, Y., Neeck, G., Wagner, S., Braun, J., Blicharshi, T., Dudek, A., Hrycai, P., Plebanski, R., Drabiszcak-Piatkowska, J., Brzezicki, J., Krogulec, M., Opris-Belinski, D., Ramazan, A.M., Tronaru, L., van de Sande, M.G., Matsievskaya, G., Schmidt, E., Stanislav, M., Yakushin, S., Ershova, O., Rebroy, A., Churchill, M.A., Flint, K.P., Greenwald, M., Howell, M.P., Kaine, J.L., Kivitz, A., Klein, S.J., Mueller, E.C., Peters, E.A., Querubin, R., Sayers, M.E., Scoville, C.D., Shanahan, J.C., Roseff, R., Hull, J.E., Mallepalli, J.R., Sebai, M.B., Kimmel, S.C., Goddard, D.H., Mease, P.J., Harris, M.D., Mabaquiao, A.R., Diegel, R.J., Thai, C., Rivera, T.L., Perez-De Jesus, A., Soto-Raices, O., Toro-Torres, R., Pantojas, C., The Lancet, 2020, 10.1016/S0140-6736(19)32971-X
  • Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry, Rahman, P., Starr, M., Haaland, D., Bessette, L., Teo, M., Rampakakis, E., Lehman, A.J., Nantel, F., BMC Rheumatology, 2020, 10.1186/s41927-020-00158-z
  • Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study, Schnitzer, T.J., Khan, A., Bessette, L., Davignon, I., Brown, M.T., Pixton, G., Prucka, W.R., Tive, L., Viktrup, L., West, C.R., Seminars in Arthritis and Rheumatism, 2020, 10.1016/j.semarthrit.2020.03.004
  • Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort, Moura, C.S., Schieir, O., Valois, M.-F., Thorne, C., Bartlett, S.J., Pope, J.E., Hitchon, C.A., Boire, G., Haraoui, B., Hazlewood, G.S., Keystone, E.C., Tin, D., Bykerk, V.P., Bernatsky, S., Baron, M., Bessette, L., Colmegna, I., Fallavollita, S., Haaland, D., Haraoui, P., Jamal, S., Jamal, S., Joshi, R., Nair, B., Panopoulos, P., Penney, C., Rubin, L., Villeneuve, E., Zummer, M., Arthritis Care and Research, 2020, 10.1002/acr.23927
  • What are the rheumatology educational preferences of family medicine residents? A descriptive study, Lagacé, S., Julien, A.-S., Rheault, C., Bessette, L., Michou, L., Clinical Rheumatology, 2020, 10.1007/s10067-020-05018-2
  • A quarter of patients time their early rheumatoid arthritis onset differently than physicians, Ellingwood, L., Kudaeva, F., Schieir, O., Bartlett, S.J., Bessette, L., Boire, G., Hazlewood, G.S., Hitchon, C., Keystone, E., Tin, D., Thorne, C., Bykerk, V.P., Pope, J., RMD Open, 2019, 10.1136/rmdopen-2019-000931
  • Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort, Nadon, V., Moltó, A., Etcheto, A., Bessette, L., Michou, L., D'Agostino, M.-A., Claudepierre, P., Wendling, D., Haraoui, P., Dougados, M., Clinical and experimental rheumatology, 2019
  • Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study, Louis Bessette, Boulos Haraoui, Andrew Chow, Isabelle Fortin, Sanjay Dixit, Majed Khraishi, Derek Haaland, Sami Elmoufti, Fabienne Staelens, Irina Bogatyreva, Jerry Syrotuik, Saeed Shaikh, Therapeutic Advances in Musculoskeletal Disease, 2019, 10.1177/1759720X19831151
  • Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression, Beaudoin, C., Moore, L., Gagné, M., Bessette, L., Ste-Marie, L.G., Brown, J.P., Jean, S., Osteoporosis International, 2019, 10.1007/s00198-019-04919-6
  • Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry, Choquette, D., Bessette, L., Alemao, E., Haraoui, B., Postema, R., Raynauld, J.-P., Coupal, L., Arthritis Research and Therapy, 2019, 10.1186/s13075-019-1917-8
  • Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response, Fleischmann, R.M., Genovese, M.C., Enejosa, J.V., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Ostor, A., Li, Y., Song, I.-H., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-215764
  • Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study, van der Heijde, D., Strand, V., Tanaka, Y., Keystone, E., Kremer, J., Zerbini, C.A.F., Cardiel, M.H., Cohen, S., Nash, P., Song, Y.-W., Tegzová, D., Gruben, D., Wallenstein, G., Connell, C.A., Fleischmann, R., Hall, S., Nicholls, D., Rischmueller, M., Baker, M.F., Bessette, L., Cividino, A.A., Haraoui, B., Niall Jones, H., Keystone, E.C., Khraishi, M., Thorne, J., Birbara, C.A., Baraf, H.S.B., Bathon, J.M., Brodsky, A.L., Cush, J.J., Dikranian, A.H., Diri, E., Dura, P.A., Lohr, K.M., Fleischmann, R.M., Griffin, R.M., Halter, D.G., Hargrove, J.K., Bouda, D.W., Reddy Pasya, S.K., Hill, G.L., Jackson, R.E., Kafka, S.P., Kaine, J.L., Katzenstein, P.L., Kempf, K.J., Kolba, K.S., Kremer, J.M., Longley, S., Mathews, S.D., Milton, A.C., Misischia, R.J., Moorman, H.A., Moreland, L.W., Niemer, M.W., Palmer, W.R., Sayers, M.E., Schuette, P.T., Shamim, T., Shergy, W.J., Sikes, D.H., Silverfield, J.C., Siva, C., Taborn, J.D., Walsh, B.T., Wells, A.F., Wolfe, S.M., Adhikari, P., Amano, K., Bae, S.-C., Chandrashekara, S., Chopra, A.K., Hsu, P.-N., Iwahashi, M., Kadel, J.K., Kawabe, Y., Koh, E.-M., Lan, J.-L., Lee, S.-K., Lin, H.-Y., Liou, L.-B., Liu, M.-F., Migita, K., Miyamoto, T., Miyasaka, N., Mori, S., Munakata, Y., Ohta, S., Park, W., Park, S.-H., Rao, U.R., Shim, S.C., Shobha, V., Takasaki, Y., Takeuchi, T., Tanaka, Y., Tohma, S., Tsai, W.-C., Ueki, Y., Veeravalli, S.C.M., Wagh, S., Yamanaka, H., Yoo, B., Batalov, A., Bichoversuska, D., Dvorak, Z., Goranov, I., Hrytsenko, H.M., Kopackova, J., Mosterova, Z., Oparanov, B., Petrov, A., Pokrzywnicka-Gajek, I., Povoroznyuk, V.V., Rosa, J., Ruzga, Z., Settas, L., Stanislavchuk, M.A., Tseluyko, V.I., Vitek, P., de Freitas Zerbini, C.A., Brenol, J.C.T., Cardiel-Rios, M.H., Escalante, W.J.O., Maldonado-Lopez, M.C., Jaller Raad, J.J., Hernandez, J.D.M., Jauregui, E.A., Keiserman, M.W., Melazzi, A.C.C., Pascual-Ramos, V., Pinto, L.T., Radominski, S.C., Ximenes, A.C., de Morales, S.V., Arthritis and Rheumatology, 2019, 10.1002/art.40803
  • Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial, Fleischmann, R., Pangan, A.L., Song, I.-H., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Ostor, A.J., Li, Y., Zhou, Y., Othman, A.A., Genovese, M.C., Arthritis and Rheumatology, 2019, 10.1002/art.41032
  • Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis, Moura, C.S., Rahme, E., Maksymowych, W.P., Abrahamowicz, M., Bessette, L., Bernatsky, S., Scandinavian Journal of Rheumatology, 2019, 10.1080/03009742.2018.1470253
  • Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study, Marshall, J.K., Bessette, L., Shear, N.H., Lebovic, G., Glass, J., Millson, B., Gaetano, T., Gazel, S., Latour, M.G., Laliberté, M.-C., Thorne, J.C., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.04.017
  • High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years, Barber, C.E.H., Schieir, O., Lacaille, D., Marshall, D.A., Barnabe, C., Hazlewood, G., Thorne, J.C., Ahluwalia, V., Bartlett, S.J., Boire, G., Haraoui, B., Hitchon, C., Keystone, E., Tin, D., Pope, J.E., Denning, L., Bykerk, V.P., Morin, F., Villeneuve, É., Baron, M., Colmegna, I., Fallavollita, S., Haaland, D., Zummer, M., Bessette, L., Akhavan, P., Rubin, L., Nair, B., Penney, C., Jamal, S., Joshi, R., Arthritis Care and Research, 2018, 10.1002/acr.23439
  • Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study, Bessette, L., Lebovic, G., Millson, B., Charland, K., Donepudi, K., Gaetano, T., Remple, V., Latour, M.G., Gazel, S., Laliberté, M.-C., Thorne, C., Rheumatology and Therapy, 2018, 10.1007/s40744-018-0109-3
  • Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study, Marshall, J.K., Bessette, L., Thorne, C., Shear, N.H., Lebovic, G., Gerega, S.K., Millson, B., Oraichi, D., Gaetano, T., Gazel, S., Latour, M.G., Laliberté, M.-C., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.02.001
  • Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial, van der Heijde, D., Cheng-Chung Wei, J., Dougados, M., Mease, P., Deodhar, A., Maksymowych, W.P., Van den Bosch, F., Sieper, J., Tomita, T., Landewé, R., Zhao, F., Krishnan, E., Adams, D.H., Pangallo, B., Carlier, H., Churchill, M., Flint, K., Gladstein, G., Greenwald, M., Howell, M., Ince, A., Kaine, J., Mehta, D., Peters, E., Querubin, R., Reveille, J., Roseff, R., Diegel, R., Thai, C., Bessette, L., Morin, F., Rahman, P., Barrera Rodriguez, A.A., Cons-Molina, F., Duran Barragan, S., Skinner, C., Pacheco Tena, C., Ramos Remus, C., Rizo Rodriguez, J.C., Hong, S.-J., Lee, Y.-A., Ju, J.H., Kang, S.W., Kim, T.-H., Lee, C.K., Lee, E.B., Lee, S.H., Park, M.-C., Shin, K., Lee, S.-H., Chen, H.-A., Chen, Y.-C., Hsieh, S.-C., Lan, J.-L., Dvorak, Z., Moravcova, R., Malcova, M., Taniguchi, Y., Kishimoto, M., Tada, K., Dobashi, H., Inui, K., Ueki, Y., Matsumoto, Y., Koyama, Y., Hatta, K., Atsumi, T., Goto, H., Matsui, K., Takakubo, Y., Neeck, G., Poddubnyy, D., Rubbert-Roth, A., Szymanska, M., Blicharski, T., Dudek, A., Racewicz, A., Wojciechowski, R., van de Sande, M., Griep, E., Nurmohamed, M., Matsievskaya, G., Shmidt, E., Stanislav, M., Yakushin, S., Ershova, O., Rebrov, A., Balazs, T., Cseuz, R., Drescher, E., Poor, G., The Lancet, 2018, 10.1016/S0140-6736(18)31946-9
  • Number, Location, and Time Since Prior Fracture as Predictors of Future Fracture in the Elderly From the General Population, Beaudoin, C., Jean, S., Moore, L., Gamache, P., Bessette, L., Ste-Marie, L.-G., Brown, J.P., Journal of Bone and Mineral Research, 2018, 10.1002/jbmr.3526
  • Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study, Schulman, E., Bartlett, S.J., Schieir, O., Andersen, K.M., Boire, G., Pope, J.E., Hitchon, C., Jamal, S., Thorne, J.C., Tin, D., Keystone, E.C., Haraoui, B., Goodman, S.M., Bykerk, V.P., Ahluwalia, V., Akhavan, P., Barra, L., Barber, C., Barnabe, C., Baron, M., Bessette, L., Bykerk, V., Colmegna, I., Fallavollita, S., Haaland, D., Hazlewood, G., Joshi, R., Kuriya, B., Larche, M., Lyddell, C., Nair, B., Penney, C., Rubin, L., Tremblay, J.L., Villeneuve, E., Zummer, M., Arthritis Care and Research, 2018, 10.1002/acr.23457
  • Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial, Burmester, G.R., Kremer, J.M., Van den Bosch, F., Kivitz, A., Bessette, L., Li, Y., Zhou, Y., Othman, A.A., Pangan, A.L., Camp, H.S., The Lancet, 2018, 10.1016/S0140-6736(18)31115-2
  • Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Nguyen, P., Julien, A.-S., Bessette, L., Fortin, P.R., Michou, L., Journal of Rheumatology, 2018, 10.3899/jrheum.170494
  • Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: Analysis from a Canadian administrative database, Bhoi, P., Bessette, L., Bell, M.J., Tkaczyk, C., Nantel, F., Maslova, K., BMJ Open, 2017, 10.1136/bmjopen-2017-015872
  • Real-world validation of the minimal disease activity index in psoriatic arthritis: An analysis from a prospective, observational, biological treatment registry, Rahman, P., Zummer, M., Bessette, L., Baer, P., Haraoui, B., Chow, A., Kelsall, J., Kapur, S., Rampakakis, E., Psaradellis, E., Lehman, A.J., Nantel, F., Osborne, B., Tkaczyk, C., BMJ Open, 2017, 10.1136/bmjopen-2017-016619
  • Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment, Bessette, L., Khraishi, M., Kivitz, A.J., Kaliyaperumal, A., Grantab, R., Poulin-Costello, M., Isaila, M., Collier, D., Rheumatology and Therapy, 2017, 10.1007/s40744-017-0079-x
  • Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Jean, S., Hudson, M., Gamache, P., Bessette, L., Fortin, P.R., Boire, G., Bernatsky, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1
  • The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis, Barra, L.J., Pope, J.E., Hitchon, C., Boire, G., Schieir, O., Lin, D., Thorne, C.J., Tin, D., Keystone, E.C., Haraoui, B., Jamal, S., Bykerk, V.P., Ahluwalia, V., Akhavan, P., Barra, L., Barber, C., Barnabe, C., Bartlett, S., Baron, M., Bessette, L., Boire, G., Bykerk, V., Colmegna, I., Fallavollita, S., Haaland, D., Haraoui, B., Hazlewood, G., Jamal, S., Keystone, E., Kuriya, B., Larche, M., Lyddell, C., Nair, B., Penney, C., Pope, J., Rubin, L., Tremblay, J.-L., Thorne, C., Villeneuve, S., Zummer, M., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew474
  • Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis, Kuriya, B., Schieir, O., Lin, D., Xiong, J., Pope, J., Boire, G., Haraoui, B., Thorne, J.C., Tin, D., Hitchon, C., Jamal, S., Keystone, E., Bykerk, V., Baron, M., Bartlett, S., Keystone, E.C., Bensen, W., Rubin, L., Bessette, L., Akhavan, P., Larche, M., Colmegna, I., Ahluwahlia, V., Penney, C., Lyddell, C., Klinkhoff, A., Zummer, M., Clinical and Experimental Rheumatology, 2017
  • Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: A 2-year multicentre exploratory study, Pelletier, J.-P., Raynauld, J.-P., Beaulieu, A.D., Bessette, L., Morin, F., de Brum-Fernandes, A.J., Delorme, P., Dorais, M., Paiement, P., Abram, F., Martel-Pelletier, J., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1149-0
  • Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis, Beaudoin, C., Jean, S., Bessette, L., Ste-Marie, L.-G., Moore, L., Brown, J.P., Osteoporosis International, 2016, 10.1007/s00198-016-3607-6
  • Dr. Roubille, et al reply, Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Gulliver, W., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Journal of Rheumatology, 2016, 10.3899/jrheum.151347
  • Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: A population-based study, Machado, M.A.D.Á., Bernatsky, S., Bessette, L., Nedjar, H., Rahme, E., BMC Musculoskeletal Disorders, 2016, 10.1186/s12891-016-1142-4
  • How to attract trainees, a pan-canadian perspective: Phase 1 of the "training the rheumatologists of tomorrow" project, Cividino, A., Bakowsky, V., Barr, S., Bessette, L., Hazel, E., Khalidi, N., Pope, J., Robinson, D., Shojania, K., Yacyshyn, E., Lohfeld, L., Crawshaw, D., Journal of Rheumatology, 2016, 10.3899/jrheum.150314
  • Identifying flares in rheumatoid arthritis: Reliability and construct validation of the OMERACT RA Flare Core Domain Set, Bykerk, V.P., Bingham, C.O., Choy, E.H., Lin, D., Alten, R., Christensen, R., Furst, D.E., Hewlett, S., Leong, A., March, L., Woodworth, T., Boire, G., Haraoui, B., Hitchon, C., Jamal, S., Keystone, E.C., Pope, J., Tin, D., Thorne, J.C., Bartlett, S.J., Boonen, A., Den Broeder, A., Fautrel, B., Guillemin, F., Lyddiatt, A., May, J.E., Montie, P., Orbai, A.-M., Pohl, C., Voshaar, M.S., Ahluwalia, V., Akhavan, P., Baron, M., Bensen, W., Bessette, L., Colmegna, I., Kinkhoff, A., Kraishi, M., Larche, M., Lyddell, C., Nair, B., Penney, C., Rubin, L., Thorne, C., Zummer, M., RMD Open, 2016, 10.1136/rmdopen-2015-000225
  • Loss of health related quality of life following low-trauma fractures in the elderly, Tarride, J.-E., Burke, N., Leslie, W.D., Morin, S.N., Adachi, J.D., Papaioannou, A., Bessette, L., Brown, J.P., Pericleous, L., Muratov, S., Hopkins, R.B., BMC Geriatrics, 2016, 10.1186/s12877-016-0259-5
  • Opioid Use and Risk of Nonvertebral Fractures in Adults with Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases, Acurcio, F.A., Moura, C.S., Bernatsky, S., Bessette, L., Rahme, E., Arthritis and Rheumatology, 2016, 10.1002/art.39422
  • Psoriasis and smoking: A systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity, Richer, V., Roubille, C., Fleming, P., Starnino, T., McCourt, C., McFarlane, A., Siu, S., Kraft, J., Lynde, C., Pope, J.E., Keeling, S., Dutz, J., Bessette, L., Gulliver, W.P., Haraoui, B., Bissonnette, R., Journal of Cutaneous Medicine and Surgery, 2016, 10.1177/1203475415616073
  • Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: Results from the Canadian Early Arthritis Cohort, Hitchon, C.A., Boire, G., Haraoui, B., Keystone, E., Pope, J., Jamal, S., Tin, D., Thorne, C., Bykerk, V.P., Ahluwalia, V., Akhavan, P., Arbillaga, H., Baron, M., Bell, M., Bensen, B., Bessette, L., Bykerk, V., Cividino, A., Colmegna, I., Haraoui, P., Kinkhoff, A., Kraishi, M., Larche, M., Lyddell, C., Menard, H., Mosher, D., Nair, B., Norris, E., Penney, C., Rubin, L., Shaw, E., Sutton, E., Villeneuve, E., Zummer, M., Bain, L., Buchignani, M., Cheng, C., Cottrell, J., Glenn, N., Guillet, C., Harris, B., Harrison, T., Moyen, M., Kislinsky, D., L'Archevêque, J., Larsen, T., Legge, G., Luc, L., Magnusson, C., Maguire, L., Matthews, J., McBain, D., Ouellet, M., Papachristos, A., Poirier, N., Sniderman, F., Strecko, J., Urroz, L., Vasconcelos, S., Wehlage, A., White, K., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew061
  • The current economic burden of illness of osteoporosis in Canada, Hopkins, R.B., Burke, N., Von Keyserlingk, C., Leslie, W.D., Morin, S.N., Adachi, J.D., Papaioannou, A., Bessette, L., Brown, J.P., Pericleous, L., Tarride, J., Osteoporosis International, 2016, 10.1007/s00198-016-3631-6
  • The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Widdifield, J., Moura, C.S., Wang, Y., Abrahamowicz, M., Michael Paterson, J., Huang, A., Beauchamp, M.-E., Boire, G., Fortin, P.R., Bessette, L., Bombardier, C., Hanly, J.G., Feldman, D., Bernatsky, S., Journal of Rheumatology, 2016, 10.3899/jrheum.151156
  • 2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. part i: Principles of the management of spondyloarthritis in Canada, Rohekar, S., Chan, J., Tse, S.M.L., Haroon, N., Chandran, V., Bessette, L., Mosher, D., Flanagan, C., Keen, K.J., Adams, K., Mallinson, M., Thorne, C., Rahman, P., Gladman, D.D., Inman, R.D., Journal of Rheumatology, 2015, 10.3899/jrheum.141000
  • 2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: Specific management recommendations, Rohekar, S., Chan, J., Tse, S.M.L., Haroon, N., Chandran, V., Bessette, L., Mosher, D., Flanagan, C., Keen, K.J., Adams, K., Mallinson, M., Thorne, C., Rahman, P., Gladman, D.D., Inman, R.D., Journal of Rheumatology, 2015, 10.3899/jrheum.141001
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Ikic, A., Beaudoin, C., Brown, J.P., Bessette, L., Fortin, P.R., Michou, L., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Ikic, A., Beaudoin, C., Brown, J.P., Bessette, L., Fortin, P.R., Michou, L., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001
  • Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Moura, C.S., Abrahamowicz, M., Beauchamp, M.-E., Lacaille, D., Wang, Y., Boire, G., Fortin, P.R., Bessette, L., Bombardier, C., Widdifield, J., Hanly, J.G., Feldman, D., Maksymowych, W., Peschken, C., Barnabe, C., Edworthy, S., Bernatsky, S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3
  • Effect of biologics on depressive symptoms in patients with psoriasis: A systematic review, Fleming, P., Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Siu, S., Kraft, J., Lynde, C., Pope, J.E., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Gulliver, W.P., Journal of the European Academy of Dermatology and Venereology, 2015, 10.1111/jdv.12909
  • Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative, Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., Gulliver, W., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Journal of Rheumatology, 2015, 10.3899/jrheum.141112
  • Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH), Barnabe, C., Sun, Y., Boire, G., Hitchon, C.A., Haraoui, B., Thorne, J.C., Tin, D., Van Der Heijde, D., Curtis, J.R., Jamal, S., Pope, J.E., Keystone, E.C., Bartlett, S., Bykerk, V.P., Kraishi, M., Zummer, M., Baron, M., Bessette, L., Akhavan, P., Rubin, L., Bensen, W., Ahluwalia, V., Nair, B., Hazlewood, G., Mosher, D., Penney, C., Lyddell, C., PLoS ONE, 2015, 10.1371/journal.pone.0135327
  • Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials, Siu, S., Haraoui, B., Bissonnette, R., Bessette, L., Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Kraft, J., Lynde, C., Gulliver, W., Keeling, S., Dutz, J., Pope, J.E., Arthritis Care and Research, 2015, 10.1002/acr.22519
  • Response to: "Drugs and cardiovascular risk in inflammatory arthritis: Another case of glucocorticoid-bashing?" by Dr Boers, Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., Gulliver, W., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2015-207419
  • Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study - Comparing site and age-specific risks in women and men, Prior, J.C., Langsetmo, L., Lentle, B.C., Berger, C., Goltzman, D., Kovacs, C.S., Kaiser, S.M., Adachi, J.D., Papaioannou, A., Anastassiades, T., Towheed, T., Josse, R.G., Brown, J.P., Leslie, W.D., Kreiger, N., Tenenhouse, A., Poliquin, S., Godmaire, S., Dumont, S., Lentle, B., Mailloux, L., Bastien, D., Robertson, L., Joyce, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Bessette, L., Gendreau, M., Hopman, W., Rees-Milton, K., Jamal, S., Cheung, A.M., Gardner-Bray, B., Pickard, L., Wojciech, P., Olszynski, Davison, K.S., Thingvold, J., Hanley, D.A., Boyd, S., Allan, J., Patel, M., Vigna, Y.M., Andjelic, N., ElhamRahme, Richards, B., Morin, S., Jackson, S., Bone, 2015, 10.1016/j.bone.2014.10.026
  • The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis, Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., Gulliver, W., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2014-206624
  • Antidepressant use and 10-year incident fracture risk: The population-based Canadian Multicentre Osteoporosis Study (CaMoS), Moura, C., Bernatsky, S., Abrahamowicz, M., Papaioannou, A., Bessette, L., Adachi, J., Goltzman, D., Prior, J., Kreiger, N., Towheed, T., Leslie, W.D., Kaiser, S., Ioannidis, G., Pickard, L., Fraser, L.-A., Rahme, E., Osteoporosis International, 2014, 10.1007/s00198-014-2649-x
  • Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines, Roussy, J.-P., Bessette, L., Bernatsky, S., Rahme, E., Lachaine, J., Calcified Tissue International, 2014, 10.1007/s00223-014-9856-5
  • Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada, Roussy, J.-P., Bessette, L., Rahme, E., Bernatsky, S., Légaré, J., Lachaine, J., Rheumatology International, 2014, 10.1007/s00296-013-2828-7
  • Rheumatoid arthritis prevalence in Quebec, Bernatsky, S., Dekis, A., Hudson, M., Pineau, C.A., Boire, G., Fortin, P.R., Bessette, L., Jean, S., Chetaille, A.L., Belisle, P., Bergeron, L., Feldman, D.E., Joseph, L., BMC Research Notes, 2014, 10.1186/1756-0500-7-937
  • The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture, Beaudoin, C., Bessette, L., Jean, S., Ste-Marie, L.-G., Brown, J.P., Osteoporosis International, 2014, 10.1007/s00198-014-2618-4
  • The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: A cross-sectional pilot study, Roubille, C., Raynauld, J.-P., Abram, F., Paiement, P., Dorais, M., Delorme, P., Bessette, L., Beaulieu, A.D., Martel-Pelletier, J., Pelletier, J.-P., Arthritis Research and Therapy, 2014, 10.1186/s13075-014-0507-z
  • Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over, Roussy, J.-P., Bessette, L., Bernatsky, S., Rahme, E., Lachaine, J., Osteoporosis International, 2013, 10.1007/s00198-013-2321-x
  • Calcium and Vitamin D intake and mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos), Langsetmo, L., Berger, C., Kreiger, N., Kovacs, C.S., Hanley, D.A., Jamal, S.A., Whiting, S.J., Genest, J., Morin, S.N., Hodsman, A., Prior, J.C., Lentle, B., Patel, M.S., Brown, J.P., Anastasiades, T., Towheed, T., Josse, R.G., Papaioannou, A., Adachi, J.D., Leslie, W.D., Davison, K.S., Goltzman, D., Tenenhouse, A., Godmaire, S., Dumont, S., Joyce, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Bessette, L., Dumont, J., Matthews, B., Josse, B., Murray, T., Gardner-Bray, B., Pickard, L., Olszynski, W.P., Thingvold, J., Allan, J., Andjelic, N., Journal of Clinical Endocrinology and Metabolism, 2013, 10.1210/jc.2013-1516
  • Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women, Jean, S., Bessette, L., Belzile, E.L., Shawn Davison, K., Candas, B., Morin, S., Dodin, S., Brown, J.P., Journal of Bone and Mineral Research, 2013, 10.1002/jbmr.1756
  • Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): A systematic literature review of randomized controlled trials, Steiman, A.J., Pope, J.E., Thiessen-Philbrook, H., Li, L., Barnabe, C., Kalache, F., Kung, T., Bessette, L., Flanagan, C., Haraoui, B., Hochman, J., Leclercq, S., Mosher, D., Thorne, C., Bykerk, V., Rheumatology International, 2013, 10.1007/s00296-012-2619-6
  • Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate, Raynauld, J.-P., Martel-Pelletier, J., Dorais, M., Haraoui, B., Choquette, D., Abram, F., Beaulieu, A., Bessette, L., Morin, F., Wildi, L.M., Pelletier, J.-P., Cartilage, 2013, 10.1177/1947603513483547
  • Algorithms can be used to identify fragility fracture cases in physician-claims databases, Jean, S., Candas, B., Belzile, É., Morin, S., Bessette, L., Dodin, S., Brown, J.P., Osteoporosis International, 2012, 10.1007/s00198-011-1559-4
  • Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women, Bessette, L., Jean, S., Lapointe-Garant, M.-P., Belzile, E.L., Davison, K.S., Ste-Marie, L.G., Brown, J.P., Osteoporosis International, 2012, 10.1007/s00198-011-1785-9
  • Sex differences in pain scores and localization in inflammatory arthritis: A systematic review and metaanalysis, Barnabe, C., Bessette, L., Flanagan, C., LeClercq, S., Steiman, A., Kalache, F., Kung, T., Pope, J.E., Haraoui, B., Hochman, J., Mosher, D., Thorne, C., Bykerk, V., Journal of Rheumatology, 2012, 10.3899/jrheum.111393
  • The burden of illness of osteoporosis in Canada, Tarride, J.-E., Hopkins, R.B., Leslie, W.D., Morin, S., Adachi, J.D., Papaioannou, A., Bessette, L., Brown, J.P., Goeree, R., Osteoporosis International, 2012, 10.1007/s00198-012-1931-z
  • The burden of illness of osteoporosis in Canadian men, Tarride, J.-E., Guo, N., Hopkins, R., Leslie, W.D., Morin, S., Adachi, J.D., Papaioannou, A., Bessette, L., Brown, J.P., Goeree, R., Journal of Bone and Mineral Research, 2012, 10.1002/jbmr.1615
  • Treating rheumatoid arthritis to target: A Canadian physician survey, Haraoui, B., Bensen, W., Bessette, L., Le Clercq, S., Thorne, C., Wade, J., Journal of Rheumatology, 2012, 10.3899/jrheum.111134
  • Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomised, double-blind, placebo-controlled pilot study using MRI, Wildi, L.M., Raynauld, J.-P., Martel-Pelletier, J., Beaulieu, A., Bessette, L., Morin, F., Abram, F., Dorais, M., Pelletier, J.-P., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.140848
  • Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture, Langsetmo, L., Nguyen, T.V., Nguyen, N.D., Kovacs, C.S., Prior, J.C., Center, J.R., Morin, S., Josse, R.G., Adachi, J.D., Hanley, D.A., Eisman, J.A., Goltzman, D., Kreiger, N., Tenenhouse, A., Poliquin, S., Godmaire, S., Berger, C., Joyce, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Josse, B., Jamal, S.A., Murray, T., Gardner-Bray, B., Papaioannou, A., Pickard, L., Olszynski, W.P., Davison, K.S., Thingvold, J., Allan, J., Patel, M., Vigna, Y., Lentle, B.C., CMAJ, 2011, 10.1503/cmaj.100458
  • Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: A systematic literature review, Barra, L., Pope, J., Bessette, L., Haraoui, B., Bykerk, V., Rheumatology, 2011, 10.1093/rheumatology/keq190
  • The burden of osteoporotic fractures beyond acute care: The Canadian Multicentre Osteoporosis Study (CaMos), Kaffashian, S., Raina, P., Oremus, M., Pickard, L., Adachi, J., Papadimitropoulos, E., Papaioannou, A., Goltzman, D., Kreiger, N., Tenenhouse, A., Poliquin, S., Godmaire, S., Berger, C., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Josse, B., Jamal, S.A., Murray, T., Gardner-Bray, B., Adachi, J.D., Papaioannou, A., Pickard, L., Olszynski, W.P., Davison, K.S., Thingvold, J., Hanley, D.A., Allan, J., Prior, J.C., Patel, M., Vigna, Y., Lentle, B.C., Age and Ageing, 2011, 10.1093/ageing/afr085
  • The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: A population-based randomized controlled trial, Bessette, L., Davison, K.S., Jean, S., Roy, S., Ste-Marie, L.G., Brown, J.P., Osteoporosis International, 2011, 10.1007/s00198-011-1533-1
  • An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis, Raynauld, J.-P., Martel-Pelletier, J., Beaulieu, A., Bessette, L., Morin, F., Choquette, D., Haraoui, B., Abram, F., Pelletier, J.-P., Seminars in Arthritis and Rheumatism, 2010, 10.1016/j.semarthrit.2009.10.003
  • Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis, Schiff, M., Bessette, L., Clinical Rheumatology, 2010, 10.1007/s10067-009-1363-0
  • Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis, Berger, C., Goltzman, D., Langsetmo, L., Joseph, L., Jackson, S., Kreiger, N., Tenenhouse, A., Davison, K.S., Josse, R.G., Prior, J.C., Hanley, D.A., Poliquin, S., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Josse, B., Jamal, S., Murray, T., Gardner-Bray, B., Adachi, J.D., Papaioannou, A., Pickard, L., Olszynski, W.P., Thingvold, J., Allan, J., Patel, M., Lentle, B., Vigna, Y., Journal of Bone and Mineral Research, 2010, 10.1002/jbmr.95
  • Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass, Kendler, D.L., Bessette, L., Hill, C.D., Gold, D.T., Horne, R., Varon, S.F., Borenstein, J., Wang, H., Man, H.-S., Wagman, R.B., Siddhanti, S., MacArios, D., Bone, H.G., Osteoporosis International, 2010, 10.1007/s00198-009-1023-x
  • Association between change in BMD and fragility fracture in women and men, Berger, C., Langsetmo, L., Joseph, L., Hanley, D.A., Davison, K.S., Josse, R.G., Prior, J.C., Kreiger, N., Tenenhouse, A., Goltzman, D., Poliquin, S., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Jamal, S., Murray, T., Gardner-Bray, B., Adachi, J.D., Papaioannou, A., Pickard, L., Olszynski, W.P., Josse, B., Thingvold, J., Allan, J., Lentle, B., Vigna, Y., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.081004
  • Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis, Russell, A., Beresniak, A., Bessette, L., Haraoui, B., Rahman, P., Thorne, C., Maclean, R., Dupont, D., Clinical Rheumatology, 2009, 10.1007/s10067-008-1060-4
  • Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective, Bessette, L., Risebrough, N., Mittmann, N., Roussy, J.-P., Ho, J., Zlateva, G., Journal of Medical Economics, 2009, 10.3111/13696990903288970
  • Factors influencing the treatment of osteoporosis following fragility fracture, Bessette, L., Jean, S., Davison, K.S., Roy, S., Ste-Marie, L.-G., Brown, J.P., Osteoporosis International, 2009, 10.1007/s00198-009-0898-x
  • Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD, Langsetmo, L., Goltzman, D., Kovacs, C.S., Adachi, J.D., Hanley, D.A., Kreiger, N., Josse, R., Papaioannou, A., Olszynski, W.P., Jamal, S.A., Tenenhouse, A., Poliquin, S., Godmaire, S., Berger, C., Joyce, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Josse, B., Murray, T., Gardner-Bray, B., Pickard, L., Davison, K.S., Thingvold, J., Allan, J., Prior, J.C., Vigna, Y., Lentle, B.C., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.090319
  • Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents, Berger, C., Langsetmo, L., Joseph, L., Hanley, D.A., Davison, K.S., Josse, R., Kreiger, N., Tenenhouse, A., Goltzman, D., Poliquin, S., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Anastassiades, T., Towheed, T., Matthews, B., Josse, B., Jamal, S., Murray, T., Gardner-Bray, B., Adachi, J.D., Papaioannou, A., Pickard, L., Olszynski, W.P., Thingvold, J., Allan, J., Prior, J.C., Vigna, Y., CMAJ, 2008, 10.1503/cmaj.071416
  • Recognizing osteoporosis and its consequences in Quebec (ROCQ): Background, rationale, and methods of an anti-fracture patient health-management programme, Bessette, L., Ste-Marie, L.-G., Jean, S., Shawn Davison, K., Beaulieu, M., Baranci, M., Bessant, J., Brown, J.P., Contemporary Clinical Trials, 2008, 10.1016/j.cct.2007.07.007
  • The care gap in diagnosis and treatment of women with a fragility fracture, Bessette, L., Ste-Marie, L.-G., Jean, S., Davison, K.S., Beaulieu, M., Baranci, M., Bessant, J., Brown, J.P., Osteoporosis International, 2008, 10.1007/s00198-007-0426-9
  • Advantages and limitations of utility assessment methods in rheumatoid arthritis, Beresniak, A., Russell, A.S., Haraoui, B., Bessette, L., Bombardier, C., Duru, G., Journal of Rheumatology, 2007
  • Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study, Hopman, W.M., Leroux, C., Berger, C., Joseph, L., Barr, S.I., Prior, J.C., Harrison, M., Poliquin, S., Towheed, T., Anastassiades, T., Goltzman, D., Tenenhouse, A., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Matthews, B., Josse, B., Murray, T., Gardner-Bray, B., Kreiger, N., Adachi, J.D., Papaioannou, A.A., Pickard, L., Olszynski, W.P., Davison, K.S., Thingvold, J., Hanley, D.A., Allan, J., Vigna, Y., BMC Public Health, 2007, 10.1186/1471-2458-7-150
  • The association between body mass index and health-related quality of life: Data from CaMos, a stratified population study, Hopman, W.M., Berger, C., Joseph, L., Barr, S.I., Gao, Y., Prior, J.C., Poliquin, S., Towheed, T., Anastassiades, T., Goltzman, D., Tenenhouse, A., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J.P., Bessette, L., Gendreau, M., Matthews, B., Josse, B., Murray, T., Gardner-Bray, B., Kreiger, N., Adachi, J.D., Papaioannou, A., Pickard, L., Olszynski, W.P., Davison, K.S., Thingvold, J., Hanley, D.A., Allan, J., Vigna, Y., Quality of Life Research, 2007, 10.1007/s11136-007-9273-6
  • Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population, Rahme, E., Choquette, D., Beaulieu, M., Bessette, L., Joseph, L., Toubouti, Y., Lelorier, J., American Journal of Medicine, 2005, 10.1016/j.amjmed.2005.03.026
  • An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Québec (Canada): The CURATA model, Labelle, M., Beaulieu, M., Paquette, D., Fournier, C., Bessette, L., Choquette, D., Rahme, E., Thivierge, R.L., Medical Teacher, 2004, 10.1080/0142159042000218669
  • CURATA: A patient health management program for the treatment of osteoarthritis in Québec: An integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications, Beaulieu, M., Choquette, D., Rahme, E., Bessette, L., Carrier, R., American Journal of Managed Care, 2004
  • Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: A placebo-controlled trial, Carette, S., Moffet, H., Tardif, J., Bessette, L., Morin, F., Frémont, P., Bykerk, V., Thorne, C., Bell, M., Bensen, W., Blanchette, C., Arthritis and Rheumatism, 2003, 10.1002/art.10954
  • Predictors of outcomes of carpal tunnel release, Katz, J.N., Losina, E., Amick III, B.C., Fossel, A.H., Bessette, L., Keller, R.B., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200105)44:5<1184::AID-ANR202>3.0.CO;2-A
  • A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia, Bessette, L., Carette, S., Fossel, A.H., Lew, R.A., Scandinavian Journal of Rheumatology, 1998, 10.1080/030097498440976
  • Comparative Responsiveness of Generic Versus Disease-Specific and Weighted Versus Unweighted Health Status Measures in Carpal Tunnel Syndrome, Bessette, L., Sangha, O., Kuntz, K.M., Keller, R.B., Lew, R.A., Fossel, A.H., Katz, J.N., Medical Care, 1998, 10.1097/00005650-199804000-00005
  • Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort, Katz, J.N., Keller, R.B., Simmons, B.P., Rogers, W.D., Bessette, L., Fossel, A.H., Mooney, N.A., Journal of Hand Surgery, 1998, 10.1016/S0363-5023(98)80058-0
  • Prevalence and predictors of long-term work disability due to carpal tunnel syndrome, Katz, J.N., Lew, R.A., Bessette, L., Punnett, L., Fossel, A.H., Mooney, N., Keller, R.B., American Journal of Industrial Medicine, 1998, 10.1002/(SICI)1097-0274(199806)33:6<543::AID-AJIM4>3.0.CO;2-R
  • Patients' preferences and their relationship with satisfaction following carpal tunnel release, Bessette, L., Keller, R.B., Liang, M.H., Simmons, B.P., Fossel, A.H., Katz, J.N., Journal of Hand Surgery, 1997, 10.1016/S0363-5023(97)80117-7
  • Predictors of return to work following carpal tunnel release, Katz, J.N., Keller, R.B., Fossel, A.H., Punnett, L., Bessette, L., Simmons, B.P., Mooney, N., American Journal of Industrial Medicine, 1997, 10.1002/(SICI)1097-0274(199701)31:1<85::AID-AJIM13>3.0.CO;2-3
  • Prognostic value of a hand symptom diagram in surgery for carpal tunnel syndrome, Bessette, L., Keller, R.B., Lew, R.A., Simmons, B.P., Fossel, A.H., Mooney, N., Katz, J.N., Journal of Rheumatology, 1997
  • Classics in spine: Surgery literature revisited, Bessette, L., Liang, M.H., Lew, R.A., Weinstein, J.N., Spine, 1996, 10.1097/00007632-199602010-00001
  • Bronchial responsiveness to methacholine in swine confinement building workers, Bessette, L., Boulet, L.P., Tremblay, G., Cormier, W., Archives of Environmental Health, 1993, 10.1080/00039896.1993.9938397

Contribution à l'enseignement aux cycles supérieurs

Direction et personnes-ressources

Vice-décanat à la recherche et aux études supérieures
Pavillon Ferdinand-Vandry
Université Laval
1050, avenue de la Médecine,  local 4645
Québec, Québec G1V 0A6
Canada

Renseignements - Secrétariat :
vdres@fmed.ulaval.ca
Téléphone 418 656-2690

Jacques Simard
Vice-doyen à la recherche et aux études supérieures
vice-doyen.recherche-et-etudes-superieures@fmed.ulaval.ca

Louise Laperrière
Adjointe au vice-doyen à la recherche et aux études supérieures
louise.laperriere@fmed.ulaval.ca 

Volet recherche
Gestion financière
Volet études aux cycles supérieurs